Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-target...
Leadership
Bahram Valamehr M.B.A., Ph.D.
President, CEO & Director
Kamal Adawi M.S., MBA
CFO & Treasurer
Cindy R. Tahl J.D.
Chief Legal & Compliance Officer and Corporate Secretary
Jessica Francis
Senior Vice President of Human Resources & Operations
Martin Hosking
Head of Research
Tunde Babalola Ph.D.
Senior Vice President of Technical Operations & Quality
Ryan Douglas
Senior Director of Investor Relations & Business Development
Andrew Henry
Senior Vice President of Clinical Operations
Yu Cai J.D., Ph.D.
Head of Intellectual Property & Assistant General Counsel
